BlackRock
DMRA

BlackRock’s Damora Therapeutics DMRA Stock Holding History

BlackRock’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82.2M Buy
3,162,068
+2,939,631
+1,322% +$71.2M ﹤0.01% 2344
2026
Q1 		$5.76M Buy
222,437
+214,917
+2,858% +$5.52M ﹤0.01% 3770
2025
Q4 		$173K Buy
7,520
+7,420
+7,420% +$129K ﹤0.01% 4758
2025
Q3 		$372 Hold
100
– – ﹤0.01% 5378
2025
Q2 		$341 Sell
100
-390
-80% -$1.15K ﹤0.01% 5385
2025
Q1 		$1.52K Hold
490
– – ﹤0.01% 5317
2024
Q4 		$2.28K Hold
490
– – ﹤0.01% 5277
2024
Q3 		$5.95K Sell
490
-358
-42% -$4.67K ﹤0.01% 5028
2024
Q2 		$10.1K Sell
848
-1,193
-58% -$18.8K ﹤0.01% 5072
2024
Q1 		$39.8K Sell
2,041
-43
-2% -$764 ﹤0.01% 4919
2023
Q4 		$37.5K Sell
2,084
-19
-0.9% -$292 ﹤0.01% 5012
2023
Q3 		$37.8K Sell
2,103
-8,836
-81% -$347K ﹤0.01% 5051
2023
Q2 		$689K Buy
10,939
+10,273
+1,542% +$559K ﹤0.01% 4393
2023
Q1 		$33.2K Hold
666
– – ﹤0.01% 5183
2022
Q4 		$19.2K Hold
666
– – ﹤0.01% 5383
2022
Q3 		$31K Buy
666
+99
+17% +$5.02K ﹤0.01% 5447
2022
Q2 		$25K Hold
567
– – ﹤0.01% 5526
2022
Q1 		$31K Hold
567
– – ﹤0.01% 5499
2021
Q4 		$42K Buy
567
+209
+58% +$16.4K ﹤0.01% 5433
2021
Q3 		$32K Buy
358
+66
+23% +$7.06K ﹤0.01% 5346
2021
Q2 		$37K Sell
292
-21,264
-99% -$2.9M ﹤0.01% 5227
2021
Q1 		$3.27M Sell
21,556
-4,639
-18% -$1.26M ﹤0.01% 4126
2020
Q4 		$8.19M Buy
+26,195
New +$9.74M ﹤0.01% 3473

Other funds holding DMRA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RCP
Remedium Capital Partners Fort Lauderdale, Florida $452M AUM
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

BlackRock's DMRA Position: Q2 2026 in Review

BlackRock increased its Damora Therapeutics (DMRA) stake by 1,322% in Q2 2026, buying an estimated $71.2M and bringing the position to 3,162,068 shares worth $82.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2344.

BlackRock first reported a position in DMRA in Q4 2020 and has held it in 23 quarters since. 104 funds tracked by Wall St. Rank hold DMRA as of Q2 2026.

  • BlackRock held 3,162,068 shares of Damora Therapeutics worth $82.2M as of Q2 2026.
  • BlackRock bought 2,939,631 Damora Therapeutics shares in Q2 2026, an estimated $71.2M.
  • Damora Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #2344 holding.
  • BlackRock first reported a position in Damora Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • 104 funds tracked by Wall St. Rank held Damora Therapeutics as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.